
mAbxience will develop and manufacture the antibody for ONC001, a CD64-targeting ADC aimed at monocytic AML and chronic myelomonocytic leukemia.
By exploiting the strong synergies in bioreactor technology and polymer manufacturing, Eppendorf has emerged as a global player in the bioprocess marketplace.
By exploiting the strong synergies in bioreactor technology and polymer manufacturing, Eppendorf has emerged as a global player in the bioprocess marketplace. With a comprehensive offering of single-use and traditional products for the growth of mammalian and microbial cells, and working volumes of 60 mL–1200 L, the Eppendorf portfolio can satisfy the demands of process development through production.
INTERPHEX Booth #3647







